European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 GuidelinesJ. Alfred Witjes, Antoine G. van der Heijden, Matthew I. Milowsky et al.|European Urology|2023Cited by 618
Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years oldÉva Compérat, Christian Pfister, S. Larré et al.|Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin|2015Cited by 227
Clinical practice guidelines for BRCA1 and BRCA2 genetic testingPascal Pujol, Julie A. Vendrell, Massimo Barberis et al.|European Journal of Cancer|2021Cited by 174
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 GuidelinesAntoine G. van der Heijden, Michael Rink, Harman Max Bruins et al.|European Urology|2025Cited by 159
FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?†Bas W.G. van Rhijn, Tahlita C.M. Zuiverloon, Laura S. Mertens et al.|European Urology|2020Cited by 89